ATNM vs TFX · rev $35.0M vs P/E 2083, rev $569.0M
Actinium Pharmaceuticals Inc (ATNM) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported TFX revenue for 2025-12-31 was $569.0M. Net income was -$714.3M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
ATNM currently screens at market cap $33.9M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the ATNM and TFX stock pages for the full models.
Not investment advice.